Red yeast rice supplements can harm your kidneys, though the risk depends heavily on the specific product, its contaminants, and your own health status. Most people who take these supplements do not develop kidney problems, but a growing number of case reports and one large-scale poisoning outbreak in Japan have documented serious acute kidney injury tied directly to red yeast rice consumption. The kidney damage can come from more than one route, and the supplement industry’s lack of standardization makes it hard to know exactly what you’re swallowing.
Multiple Pathways to Kidney Damage
Red yeast rice is made by fermenting rice with a mold called Monascus purpureus, which produces a compound called monacolin K. That compound is chemically identical to lovastatin, a prescription cholesterol-lowering drug.1PubMed Central. Production of red yeast rice rich in monacolin K by variable temperature solid fermentation of Monascus purpureus This means red yeast rice is, in effect, an unregulated statin. Statins at high doses or in combination with certain other drugs can cause rhabdomyolysis, a condition where muscle tissue breaks down and floods the bloodstream with proteins that clog and damage the kidneys. One published case involved a 76-year-old man who had been taking an anti-cancer drug and added a red yeast rice supplement. He developed progressive muscle weakness, soreness, and acute kidney injury from rhabdomyolysis. After stopping both medications and receiving dialysis, he recovered.2PubMed Central. Rhabdomyolysis-induced acute kidney injury after administration of a red yeast rice supplement – Section: Abstract
But rhabdomyolysis isn’t the only way these supplements can hurt your kidneys. The fermentation process that produces monacolin K can also generate citrinin, a mycotoxin with well-documented kidney-toxic properties. Citrinin is a secondary metabolite of the same mold genera used to make red yeast rice, and it has nephrotoxic, liver-toxic, and embryo-toxic effects.3MDPI / Toxins. Dietary Supplements Based on Red Yeast Rice-A Source of Citrinin? Even products marketed as “citrinin-free” have been found to contain measurable levels, as we’ll see in the section on product variability.
A third and more recently identified threat is contamination by environmental fungi that infiltrate the manufacturing process. In 2024, a compound called puberulic acid, produced by a mold called Penicillium adametzioides that had colonized a Japanese red yeast rice factory, was identified as a cause of kidney poisoning in dozens of people.4PubMed Central. Mechanism of puberulic acid contamination in red yeast rice tablets that caused a serious food poisoning outbreak in Japan That compound causes direct injury to the kidney’s proximal tubules, the structures responsible for reabsorbing nutrients from urine back into the blood.5PubMed. Evaluation of Puberulic Acid-Induced Nephrotoxicity Using 3D-RPTEC
The 2024 Japan Outbreak
In March 2024, Japanese health authorities traced a cluster of kidney injuries to a specific red yeast rice supplement called Benikoji CholesteHelp, manufactured by Kobayashi Pharmaceutical. The scale of the outbreak drew international attention and triggered a nationwide survey by the Japanese Society of Nephrology. An interim report covering findings through the end of March 2024 identified 47 patients with suspected kidney injury from the products, and the majority showed signs of Fanconi syndrome, a condition where the kidney tubules fail to reabsorb essential substances like potassium, phosphate, uric acid, and glucose.6Kidney Medicine. Acute Kidney Injury Associated With Red Yeast Rice (Beni-kōji) Supplement – Section: Introduction
Investigators found that the contaminating toxin, puberulic acid, was produced by a strain of Penicillium adametzioides that had taken hold in the manufacturing facility. The fungus was isolated from wipe samples collected at both the Wakayama and Osaka factories, and all the puberulic acid-producing strains clustered into a single genetic group, confirming a common contamination source.4PubMed Central. Mechanism of puberulic acid contamination in red yeast rice tablets that caused a serious food poisoning outbreak in Japan The puberulic acid was present at high levels in tablets from the affected lot but absent from normal tablets produced before the contamination event.
The outbreak was significant not just for the number of people harmed but for what it revealed about supplement manufacturing. Puberulic acid had not been on anyone’s radar as a food-safety risk before this. Its mutagenic potential hadn’t even been studied until after the poisoning happened.7PubMed Central. Assessment of mutagenic potential of puberulic acid contaminated in red yeast rice (beni-koji) health food supplements The incident underscored a basic vulnerability: when you ferment a natural product in an industrial setting, environmental molds can sneak in and produce toxins that no one is testing for.
What Kidney Injury From Red Yeast Rice Looks Like
The kidney damage reported across multiple case studies follows a fairly consistent pattern. Patients typically present with elevated creatinine levels in the blood, a standard marker of declining kidney function. In one well-documented case, a patient’s serum creatinine reached 4.26 mg/dL, far above the normal range. Urinalysis showed protein in the urine, sugar in the urine (despite no diabetes), and extremely high levels of markers that indicate tubular damage.8Clinical Kidney Journal. Acute kidney tubular injury after ingestion of red yeast rice supplement – Section: CASE REPORT Low potassium and low uric acid in the blood rounded out the picture of Fanconi syndrome.
In another case, a 58-year-old woman who had been taking the Benikoji CholesteHelp supplement developed creatinine levels of 2.75 mg/dL. A kidney biopsy showed tubulointerstitial nephritis with immune cells infiltrating the tissue between the tubules, along with tubular atrophy and early fibrosis (scarring).9PubMed Central. Successful treatment of acute tubulointerstitial nephritis probably due to Benikoji CholesteHelp®, a supplement containing red yeast rice Other biopsied patients showed a similar picture: lymphocytic infiltration of the kidney tissue, meaning the body’s immune cells were attacking the kidney structures themselves.10PubMed Central. Successful Resolution of Suspected Red Yeast Rice-induced Nephropathy
The consistent involvement of the proximal tubules is telling. These are the kidney structures responsible for reclaiming useful molecules from the filtrate before it becomes urine. When they fail, substances like glucose, phosphate, amino acids, and uric acid spill into the urine instead of being reabsorbed. That’s the hallmark of Fanconi syndrome, and it was the dominant finding across the Japanese outbreak cases.
Who Faces the Greatest Risk
If you already have reduced kidney function, the evidence suggests you’re more vulnerable. One case report explicitly noted that the affected patient had mild kidney dysfunction before starting the supplement, and the authors proposed that pre-existing chronic kidney disease may have increased susceptibility to the acute injury.11Clinical Kidney Journal. Acute kidney tubular injury after ingestion of red yeast rice supplement – Section: DISCUSSION This makes biological sense: kidneys already operating with reduced reserve have less margin to absorb an additional toxic hit.
The case series from Japan illustrates a wide age range of affected individuals. Published reports describe patients as young as 42, with no prior kidney disease, and as old as 83, with advanced diabetic kidney disease who experienced further deterioration after starting red yeast rice.12PubMed Central. Renal Injuries Induced by Supplements Containing Red Yeast Rice People taking medications that interact with statins face an additional layer of risk. The rhabdomyolysis case mentioned earlier involved a man on abiraterone, a cancer drug, and the authors speculated that the combination of statins from the supplement with that medication raised his rhabdomyolysis risk substantially.2PubMed Central. Rhabdomyolysis-induced acute kidney injury after administration of a red yeast rice supplement – Section: Abstract
Drugs known to interact badly with statins include certain antifungals, some antibiotics, HIV protease inhibitors, cyclosporine, and other cholesterol medications like gemfibrozil. If you’re on any of these and taking red yeast rice without telling your doctor, you’re essentially combining a statin with a drug that raises statin levels in your blood, without any medical oversight of the dose.
The Product Variability Problem
One of the most alarming aspects of red yeast rice supplements is how wildly they vary from product to product and even from what’s printed on the label. A study of commercially available supplements found that the actual monacolin K content per capsule ranged from 0.10 mg to 10.09 mg, a hundred-fold difference. One product with almost no monacolin K had the highest citrinin contamination at 189 micrograms per capsule, and four of the twelve products tested had elevated citrinin levels.13JAMA Internal Medicine. Marked Variability of Monacolin Levels in Commercial Red Yeast Rice Products – Section: Results
A more recent European analysis of supplements from retail stores and online marketplaces painted a similarly chaotic picture. Nine products contained less monacolin K than their labels claimed (by as much as 83% less), while 24 products contained more than stated (up to 266% more). The actual daily dose ranged over thirty-fold, from 1.2 mg to 36 mg per day. Every single product tested contained detectable citrinin, with levels spanning from 100 to over 25,000 micrograms per kilogram. Only one product met the stricter citrinin limit that the EU introduced in 2020.14PubMed Central. Risk Assessment of RYR Food Supplements: Perception vs. Reality – Section: Results and Discussion
This means two people taking “the same dose” of red yeast rice from different brands could be getting dramatically different exposures to both the active ingredient and to kidney-toxic contaminants. You have no reliable way to know, from the label alone, what’s actually in the capsule you’re swallowing.
Recovery and Treatment
The good news from the published case reports is that many patients recovered kidney function after stopping the supplement, though the road was not always quick or easy. In several of the Japanese cases, patients required dialysis during the acute phase. One patient who was diagnosed with acute tubular injury and acute interstitial nephritis was started on oral steroids (prednisolone, 50 mg daily) to suppress the immune-mediated attack on the kidney tubules. Her kidney function gradually improved, and she was able to come off dialysis after about 12 days of steroid treatment.15American Journal of Kidney Diseases. Three Cases of Red Yeast Rice–Containing Supplement-Induced Acute Kidney Injury and Fanconi Syndrome – Section: Case Report
Another patient with rhabdomyolysis-induced kidney injury responded well to a combination of hemodialysis and hemoperfusion after discontinuing both red yeast rice and the interacting cancer drug.2PubMed Central. Rhabdomyolysis-induced acute kidney injury after administration of a red yeast rice supplement – Section: Abstract However, the biopsied kidneys from some patients already showed fibrotic changes, suggesting that some degree of permanent damage may occur if the exposure continues long enough before detection.9PubMed Central. Successful treatment of acute tubulointerstitial nephritis probably due to Benikoji CholesteHelp®, a supplement containing red yeast rice Early recognition and prompt discontinuation appear to be the most important factors in whether kidney function bounces back fully.
What European Regulators Have Concluded
The European Food Safety Authority (EFSA) has taken a notably cautious stance. After reviewing additional safety data, the agency reiterated concerns that exposure to monacolin K from red yeast rice at doses as low as 3 mg per day could lead to severe adverse effects on the musculoskeletal system, including rhabdomyolysis, as well as liver damage. EFSA concluded that the available data did not allow establishing the safety of monacolins in red yeast rice supplements even below 3 mg per day, and that no daily intake could be identified that would not raise safety concerns for the general population or vulnerable subgroups.16EFSA Journal. Scientific Opinion on additional scientific data related to the safety of monacolins from red yeast rice submitted pursuant to Article 8(4) of Regulation (EC) No 1925/2006
That’s a remarkably strong statement from a regulatory body. It means EFSA was unable to find any dose that it considered safe for unrestricted consumer use. In practice, red yeast rice supplements remain available in many markets, including the United States, where the FDA regulates them as dietary supplements rather than drugs. The EU has had a maximum citrinin limit in place since 2014, tightened in 2020, but as the product-testing studies show, compliance is spotty at best.
The regulatory disconnect creates a confusing landscape for consumers. Red yeast rice is sold in health food stores alongside vitamins and herbal teas, giving the impression of a gentle, natural product. But it contains a pharmaceutical-grade compound at unpredictable doses, alongside contaminants that a prescription statin would never contain, all without the medical monitoring that a doctor would require if prescribing lovastatin.
How Red Yeast Rice Compares to Prescription Statins for Kidney Safety
Prescription statins like lovastatin, atorvastatin, and rosuvastatin undergo rigorous manufacturing to ensure precise dosing and absence of contaminants. They come with known drug-interaction profiles, are monitored through blood tests, and have decades of safety data behind them. Red yeast rice delivers the same active molecule but strips away every safeguard.
The kidney risks specific to red yeast rice that do not apply to prescription statins include citrinin exposure, which is an inherent byproduct of the fermentation process, and contamination by environmental fungi like the Penicillium adametzioides that caused the Japan outbreak. Prescription lovastatin, synthesized in a controlled pharmaceutical setting, does not carry these risks. The rhabdomyolysis pathway exists for both, but with a prescription, your doctor knows the exact dose you’re taking and can screen for drug interactions and monitor your creatine kinase levels if you develop muscle symptoms.
People who turn to red yeast rice often do so because they believe it’s gentler than a prescription statin or because they experienced muscle aches on a statin and hope the “natural” version will be better tolerated. The irony is that monacolin K is the same molecule responsible for statin-related muscle problems. If you had muscle issues on lovastatin, you may well have the same issues with red yeast rice, plus the added risks of unknown dose and contamination.
Signs You Should Stop and Seek Medical Attention
If you’re currently taking a red yeast rice supplement, certain symptoms should prompt you to stop immediately and see a doctor. Unexplained muscle pain or weakness, especially if accompanied by dark-colored urine, can signal rhabdomyolysis. A marked decrease in urine output, swelling in your legs, or sudden fatigue could indicate declining kidney function. Nausea and loss of appetite sometimes accompany acute kidney injury but are easy to dismiss as unrelated.
Because the kidney damage from red yeast rice often involves the proximal tubules, some of the earliest biochemical signs may not cause obvious symptoms. Low potassium can produce muscle cramps or heart palpitations. Low phosphate can cause weakness and bone pain. These electrolyte disturbances from Fanconi syndrome can be subtle and creep up gradually, making them easy to overlook until kidney function has deteriorated significantly. If your doctor orders routine blood work and finds unexplained drops in potassium, phosphate, or uric acid alongside rising creatinine, mention any supplement use, including red yeast rice.
The broader lesson from the published cases is that red yeast rice is not inert just because it’s sold without a prescription. It contains a real drug at an uncertain dose, frequently alongside kidney-toxic contaminants. For people who need cholesterol management, working with a physician to find an appropriate prescription statin, or an alternative if statins aren’t tolerated, provides both the cholesterol benefit and a safety framework that red yeast rice cannot match.